Nobel Conference 56Resources to Learn More


As cancer cells grow, they become increasingly difficult for the immune system to combat. Immunotherapy treatments work with the immune system to overcome these issues. In 2017, researchers—led by Nobel Conference presenter Carl June—developed the first immunotherapy treatment to use gene therapy. This treatment, called Kymriah, involves taking a blood sample from the patient to gather healthy immune system cells, known as a T-cells. The cells are then genetically modified in the lab to give them superpowers. When they are put back in the patient, they can destroy cancer cells that they previously couldn’t find or were too weak to kill. 

What is Immunotherapy from the Cancer Research Institute
Immunotherapy for Cancer from the National Cancer Institute
Dr. Carl June’s CAR T-Cell Journey and the Cancer Treatment Revolution A one-hour podcast featuring Nobel Conference speaker Carl June
Beating Leukemia with Groundbreaking CAR T Therapy A one-hour podcast
A “Living Drug” that Could Change the Way We Treat Cancer TED talk by Nobel Conference speaker Carl June
Dr. Carl June CAR T Therapy  30-minute podcast
The Promise and Price of Cellular Therapies from the Newyorker
Car T-Cell Therapy and Its Side Effects from the American Cancer Society
Cancer Vaccines and Their Side Effects from the American Cancer Society
Immunotherapy to Treat Cancer from the National Cancer Institute

Learn more about cancer topics